Denali Therapeutics Inc (DNLI) Insider Trading
- $4,950,000.00
- $330,759,685.79
- Oct. 18, 2024
- Ryan J Watts
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
Oct. 18, 2024 | CEO | 40,000 | $27.69 | Sell | $1,107,600.00 | |
Sept. 30, 2024 | Director | 30,000 | $29.03 | Sell | $870,900.00 | |
July 1, 2024 | Director | 30,000 | $22.12 | Sell | $663,600.00 | |
June 6, 2024 | Director | 1,458 | $21.73 | Sell | $31,682.34 | |
April 15, 2024 | Director | 1,666 | $18.29 | Sell | $30,471.14 | |
April 1, 2024 | Director | 92,500 | $20.50 | Sell | $1,896,250.00 | |
Feb. 15, 2024 | Director | 1,666 | $18.37 | Sell | $30,604.42 | |
Feb. 13, 2024 | CEO | 9,589 | $17.29 | Sell | $165,793.81 | |
Feb. 13, 2024 | Insider | 2,784 | $17.29 | Sell | $48,135.36 | |
Feb. 13, 2024 | Director | 2,750 | $17.29 | Sell | $47,547.50 | |
Jan. 16, 2024 | Director | 1,666 | $18.42 | Sell | $30,687.72 | |
Jan. 10, 2024 | Insider | 4,668 | $19.02 | Sell | $88,785.36 | |
Jan. 9, 2024 | CEO | 7,818 | $19.78 | Sell | $154,640.04 | |
Jan. 5, 2024 | CEO | 17,483 | $19.43 | Sell | $339,694.69 | |
Jan. 5, 2024 | Insider | 9,972 | $19.43 | Sell | $193,755.96 | |
Jan. 5, 2024 | Director | 3,208 | $19.43 | Sell | $62,331.44 | |
Dec. 15, 2023 | Director | 1,666 | $23.39 | Sell | $38,967.74 | |
Nov. 15, 2023 | Director | 1,666 | $19.13 | Sell | $31,870.58 | |
Oct. 16, 2023 | Director | 1,666 | $20.66 | Sell | $34,419.56 | |
Sept. 15, 2023 | Director | 1,666 | $23.62 | Sell | $39,350.92 | |
Aug. 23, 2023 | Insider | 2,522 | $23.22 | Sell | $58,560.84 | |
Aug. 21, 2023 | Director | 1,419 | $22.60 | Sell | $32,069.40 | |
Aug. 21, 2023 | CEO | 2,309 | $22.59 | Sell | $52,160.31 | |
Aug. 21, 2023 | Insider | 2,478 | $22.60 | Sell | $56,002.80 | |
Aug. 15, 2023 | Director | 1,666 | $24.30 | Sell | $40,483.80 | |
Aug. 14, 2023 | Insider | 2,768 | $23.79 | Sell | $65,850.72 | |
Aug. 10, 2023 | CEO | 2,526 | $25.03 | Sell | $63,225.78 | |
Aug. 10, 2023 | Insider | 2,857 | $24.15 | Sell | $68,996.55 | |
July 17, 2023 | Director | 1,666 | $29.60 | Sell | $49,313.60 | |
July 17, 2023 | Insider | 10,000 | $29.60 | Sell | $296,000.00 | |
June 28, 2023 | Director | 1,666 | $29.84 | Sell | $49,713.44 | |
May 15, 2023 | Insider | 10,000 | $28.60 | Sell | $286,000.00 | |
April 20, 2023 | CEO | 200 | $25.00 | Sell | $5,000.00 | |
April 12, 2023 | Insider | 5,102 | $25.04 | Sell | $127,754.08 | |
Feb. 13, 2023 | Insider | 2,548 | $30.10 | Sell | $76,694.80 | |
Feb. 13, 2023 | Director | 2,119 | $30.10 | Sell | $63,781.90 | |
Feb. 13, 2023 | CEO | 33,815 | $30.08 | Sell | $1,017,155.20 | |
Feb. 10, 2023 | Insider | 818 | $29.80 | Sell | $24,376.40 | |
Feb. 10, 2023 | CEO | 25,000 | $29.10 | Sell | $727,500.00 | |
Feb. 8, 2023 | Insider | 1,521 | $30.88 | Sell | $46,968.48 | |
Feb. 8, 2023 | Director | 1,377 | $30.88 | Sell | $42,521.76 | |
Jan. 17, 2023 | Insider | 10,000 | $29.53 | Sell | $295,300.00 | |
Jan. 9, 2023 | Insider | 1,459 | $28.48 | Sell | $41,552.32 | |
Jan. 6, 2023 | Insider | 1,451 | $28.67 | Sell | $41,600.17 | |
Jan. 5, 2023 | Director | 2,970 | $28.44 | Sell | $84,466.80 | |
Jan. 4, 2023 | CEO | 5,029 | $28.73 | Sell | $144,483.17 | |
Jan. 4, 2023 | Insider | 2,913 | $28.69 | Sell | $83,573.97 | |
Nov. 23, 2022 | Director | 20,000 | $30.48 | Sell | $609,600.00 | |
Nov. 1, 2022 | Director | 8,748 | $30.20 | Sell | $264,189.60 | |
Sept. 28, 2022 | Director | 20,000 | $30.82 | Sell | $616,400.00 |
Insiders are both buying and selling Denali Therapeutics Inc stock.
The insider traders at Denali Therapeutics Inc are: Ryan J Watts, Alexander O Schuth, Carole Ho, Steve E Krognes, Marc Tessier-Lavigne, Vicki L Sato, Douglas K Bratton, Alexander O. Schuth, Vicki L. Sato, Ryan J. Watts, Steve E. Krognes, David P Schenkein, Jennifer E Cook, and David P. Schenkein
The most active insider trader at Denali Therapeutics Inc is Ryan J Watts with 36 trades.
Douglas K Bratton has sold the most Denali Therapeutics Inc stock with a total value of $382,924,890.09.
Douglas K Bratton has bought the most Denali Therapeutics Inc stock with a total value of $9,900,000.00.
The most recent insider trade for Denali Therapeutics Inc was on Oct. 18, 2024.
The single biggest insider buy for Denali Therapeutics Inc was from Douglas K Bratton with a total value of $4,950,000.00 on Dec. 12, 2017.
The single biggest insider sell for Denali Therapeutics Inc was from Douglas K Bratton with a total value of $144,091,870.00 on Feb. 12, 2021.